Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Family Practice · KENHORST, PA · NPI 1912984097
Verified facts
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
We did not find matching Open Payments records for this doctor in the selected program year.
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 991 | 287 |
| Amlodipine Besylate | Amlodipine Besylate | 970 | 256 |
| Losartan Potassium | Losartan Potassium | 697 | 188 |
| Metoprolol Succinate | Metoprolol Succinate | 553 | 138 |
| Levothyroxine Sodium | Levothyroxine Sodium | 518 | 123 |
| Pantoprazole Sodium | Pantoprazole Sodium | 472 | 123 |
| Lisinopril | Lisinopril | 440 | 131 |
| Metoprolol Tartrate | Metoprolol Tartrate | 390 | 104 |
| Simvastatin | Simvastatin | 387 | 110 |
| Hydrochlorothiazide | Hydrochlorothiazide | 379 | 112 |
| Omeprazole | Omeprazole | 360 | 104 |
| Sertraline Hcl | Sertraline Hcl | 330 | 88 |
| Metformin Hcl | Metformin Hcl | 310 | 87 |
| Eliquis | Apixaban | 304 | 72 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 285 | 78 |
| Furosemide | Furosemide | 241 | 67 |
| Potassium Chloride | Potassium Chloride | 226 | 61 |
| Gabapentin | Gabapentin | 206 | 49 |
| Tamsulosin Hcl | Tamsulosin Hcl | 183 | 53 |
| Pravastatin Sodium | Pravastatin Sodium | 164 | 46 |
| Clonazepam | Clonazepam | 156 | 44 |
| Trazodone Hcl | Trazodone Hcl | 147 | 50 |
| Allopurinol | Allopurinol | 143 | 42 |
| Escitalopram Oxalate | Escitalopram Oxalate | 142 | 32 |
| Synthroid | Levothyroxine Sodium | 131 | 28 |
| Tramadol Hcl | Tramadol Hcl | 130 | 40 |
| Alendronate Sodium | Alendronate Sodium | 109 | 22 |
| Citalopram Hbr | Citalopram Hydrobromide | 101 | 27 |
| Clopidogrel | Clopidogrel Bisulfate | 99 | 27 |
| Hydralazine Hcl | Hydralazine Hcl | 98 | 25 |
| Bupropion Xl | Bupropion Hcl | 97 | 23 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 96 | 35 |
| Duloxetine Hcl | Duloxetine Hcl | 92 | 20 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 89 | 26 |
| Xarelto | Rivaroxaban | 88 | 18 |
| Jardiance | Empagliflozin | 83 | 22 |
| Klor-Con M20 | Potassium Chloride | 83 | 25 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 81 | 21 |
| Lorazepam | Lorazepam | 80 | 25 |
| Meloxicam | Meloxicam | 79 | 19 |
| Nateglinide | Nateglinide | 79 | 22 |
| Famotidine | Famotidine | 78 | 29 |
| Ezetimibe | Ezetimibe | 77 | 25 |
| Donepezil Hcl | Donepezil Hcl | 75 | 19 |
| Montelukast Sodium | Montelukast Sodium | 75 | 23 |
| Valsartan | Valsartan | 75 | 20 |
| Carvedilol | Carvedilol | 74 | 19 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 73 | 20 |
| Trulicity | Dulaglutide | 71 | suppressed |
| Ozempic | Semaglutide | 68 | 12 |
| Spironolactone | Spironolactone | 60 | 17 |
| Buspirone Hcl | Buspirone Hcl | 58 | 15 |
| Fluticasone Propionate | Fluticasone Propionate | 58 | 21 |
| Alprazolam | Alprazolam | 56 | 17 |
| Atenolol | Atenolol | 56 | 16 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 54 | 14 |
| Glimepiride | Glimepiride | 53 | 16 |
| Memantine Hcl | Memantine Hcl | 53 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 53 | 16 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 50 | suppressed |
| Ramipril | Ramipril | 50 | 12 |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 48 | 13 |
| Benazepril Hcl | Benazepril Hcl | 48 | 13 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 48 | 18 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 46 | 14 |
| Prednisone | Prednisone | 45 | 29 |
| Mirtazapine | Mirtazapine | 44 | 11 |
| Finasteride | Finasteride | 43 | 14 |
| Nifedipine Er | Nifedipine | 42 | 11 |
| Primidone | Primidone | 41 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 40 | 13 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 37 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 36 | 21 |
| Farxiga | Dapagliflozin Propanediol | 34 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 33 | 25 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 32 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 30 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 30 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 30 | 13 |
| Glipizide Er | Glipizide | 29 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 29 | suppressed |
| Januvia | Sitagliptin Phosphate | 29 | suppressed |
| Verapamil Er | Verapamil Hcl | 25 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 24 | suppressed |
| Myrbetriq | Mirabegron | 24 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 24 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 24 | 12 |
| Klor-Con M10 | Potassium Chloride | 23 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 23 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 22 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 21 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 20 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 20 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 20 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 20 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 20 | suppressed |
| Lidocaine | Lidocaine | 19 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 19 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 19 | 11 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 18 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 18 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 18 | suppressed |
| Baclofen | Baclofen | 17 | suppressed |
| Celecoxib | Celecoxib | 17 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 17 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 16 | suppressed |
| Irbesartan | Irbesartan | 16 | suppressed |
| Lovastatin | Lovastatin | 16 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 16 | suppressed |
| Fenofibrate | Fenofibrate | 15 | suppressed |
| Trospium Chloride | Trospium Chloride | 15 | suppressed |
| Amoxicillin | Amoxicillin | 14 | 13 |
| Fenofibric Acid | Fenofibric Acid (Choline) | 14 | suppressed |
| Levemir Flexpen | Insulin Detemir | 14 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 14 | suppressed |
| Methimazole | Methimazole | 14 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 14 | suppressed |
| Temazepam | Temazepam | 14 | suppressed |
| Topiramate | Topiramate | 14 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 14 | suppressed |
| Estazolam | Estazolam | 13 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 13 | suppressed |
| Rabeprazole Sodium | Rabeprazole Sodium | 13 | suppressed |
| Bumetanide | Bumetanide | 12 | suppressed |
| Buprenorphine | Buprenorphine | 12 | suppressed |
| Nitroglycerin | Nitroglycerin | 12 | suppressed |
| Nystatin | Nystatin | 12 | suppressed |
| Pregabalin | Pregabalin | 12 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Aripiprazole | Aripiprazole | 11 | suppressed |
| Chlorthalidone | Chlorthalidone | 11 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 11 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 11 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 11 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 11 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 11 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error